Re: A couple Q2 events for Zenith

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: A couple Q2 events for Zenith

in response to

Re: A couple Q2 events for Zenith

BearDownAZ

posted on May 10, 2017 12:32PM

BDAZ - Just from keeping my ear to the ground. Heard this from a couple of unrelated people.